Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy - Wikidata - awgldk - TriplyDB

Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy

Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy

http://www.wikidata.org/entity/Q36126873

about

Management of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomy The Spectrum of Renal Allograft Failure Approach to the Highly Sensitized Kidney Transplant Candidate.HLA sensitisation: can it be prevented?Timing of return to dialysis in patients with failing kidney transplants.Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization.Immunosuppression in the failing and failed transplant kidney: optimizing outcomes.Graft nephrectomy in children.Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts.Allelic and Epitopic Characterization of Intra-Kidney Allograft Anti-HLA Antibodies at Allograft Nephrectomy.Immunosuppression after renal allograft failure: a survey of US practices.Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA Antibodies.Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells.

P2860

Q27693912-7A69F7FF-4023-476F-A6FC-CCF7DEE76BEA Q28554254-E5150731-C1C9-4A5B-99F3-028AC5F064EC Q30277267-82986076-ED1C-4621-B379-FC530D9D2C07 Q35097898-3A2AFB6F-F4E2-49BA-8FCD-93F3D894D207 Q38135467-6D2B2E62-E63B-45D2-B3E4-5882DDABAE3B Q38255293-70B9FFF5-5BF9-44A5-A95C-A7808C217EDB Q38542030-B51DE65C-255C-4F56-84CC-E63CAC40E9E9 Q38669147-1886B37C-6C2E-424E-8199-1BD57B9D7B32 Q39116608-45C9B978-D260-4B3E-9491-4F08963E915D Q39612344-4FEECCE2-13F3-4A8B-BAA5-18008831963E Q42622894-657C0BCE-8A11-460A-B354-8F8575EA3E18 Q48170211-8B627739-FB53-4781-BD39-74495B049CB7 Q50247701-4EEA6059-9868-4926-9CF5-EEFC088AD7AA Q52852198-FCF37700-55EE-41AB-8CE0-6D19147BF085 Q53108441-5A90F2F1-4B91-4BE6-B6BB-6D576C0C3E46 Q55373807-EE82F797-E843-4009-AD71-FC999C03D84C

P2860

Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy

http://www.wikidata.org/entity/Q36126873

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@ast

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@en

type

label

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@ast

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@en

prefLabel

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@ast

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@en

P1433

Q36126873-DF7CF12A-0A24-4E1E-820E-C6DAAB8F5D83

P1476

Q36126873-D54E7702-C4DD-4E2E-827E-D7BF6EA3EDAB

P2093

Q36126873-52C4479E-1540-447D-BB75-7C18F1ED92DF

Q36126873-675948BB-5036-4C75-B689-E2D7DDBF69AE

Q36126873-92AC821D-4E66-4784-93D1-E15434840468

Q36126873-A602C611-870C-41C9-BD2B-1B4BFEE0C10D

Q36126873-A7CD4763-0A0E-49E7-BC09-43531594271A

Q36126873-A9448322-FE43-445E-992C-7CDD46E36349

Q36126873-B09AF9A5-1DF0-482C-84E6-3AC8371361F6

Q36126873-B6472387-850A-4250-B342-3198360DA1B1

Q36126873-C65D6FD8-645F-4B1D-8CCC-98783B33E87F

Q36126873-D0726C02-8FFB-4C76-B8CA-95A0897E2562

P2860

Q36126873-1BCA834F-321E-4684-AEDB-3592AEBC2F02

Q36126873-1CECFD58-4B8D-4679-BC4B-D9ABA93EA791

Q36126873-21FB9B6A-EA14-4FBA-95B2-61C64D31DCD1

Q36126873-3E88EDA1-A519-4872-B0B5-F2BA7F8A8599

Q36126873-49610DC9-F600-4BE2-89E1-DACE3ECAD8E3

Q36126873-534D1CAC-C0C8-45C3-865C-180A6B3C383D

Q36126873-6A1C4423-5BD8-416E-9EE6-45C2DFA6765D

Q36126873-6D9AA9BE-6113-4BAC-BC82-2227375517B0

Q36126873-7A519D5D-505A-4F76-B091-7C759A009ADA

Q36126873-8798F5A8-1B46-4093-BFC8-F778DB15F077

P304

Q36126873-F4E2FE2E-68E3-41D5-828A-FADF47439097

P31

Q36126873-F3C51B44-9E6A-4C6D-BAAF-35720FC8222C

P356

Q36126873-1EA31DCF-C743-4B44-8F50-B2D57A169AD9

P433

Q36126873-C8F1355F-AE41-4575-99E6-89002375EB94

P478

Q36126873-26F84FDA-D715-418E-A7F7-ECEC40977F33

P50

Q36126873-08A7376E-39A4-4D39-A2FB-C505FB9AF776

Q36126873-3E2D6269-9CCD-4EAE-98C7-F784B45F9BD7

Q36126873-8D5324E2-6E08-4436-87DC-2431932B0DA1

Q36126873-96939BD5-07B4-48E5-A536-2749BF08409A

P577

Q36126873-7D1A3E41-7382-42EC-A1E6-F09B269C8210

P698

Q36126873-F3AC9A34-3939-4386-A369-56735F0B8AF5

P932

Q36126873-FE8B2E5B-1BEA-4F43-853A-4EE5A167EBB8

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Donor-specific antibodies afte ...... thout an allograft nephrectomy

@en

P2093

Antoine Blancher

http://www.w3.org/2001/XMLSchema#string

Arnaud Del Bello

http://www.w3.org/2001/XMLSchema#string

Federico Sallusto

http://www.w3.org/2001/XMLSchema#string

Joelle Guitard

http://www.w3.org/2001/XMLSchema#string

Laure Esposito

http://www.w3.org/2001/XMLSchema#string

Laurence Lavayssière

http://www.w3.org/2001/XMLSchema#string

Marie Béatrice Nogier

http://www.w3.org/2001/XMLSchema#string

Marylise Fort

http://www.w3.org/2001/XMLSchema#string

Nicolas Congy-Jolivet

http://www.w3.org/2001/XMLSchema#string

Olivier Cointault

http://www.w3.org/2001/XMLSchema#string

P2860

Transplant nephrectomy improves survival following a failed renal allograft.

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

Humoral theory of transplantation.

Humoral immunity in renal transplantation: clinical significance and therapeutic approach.

Solid phase HLA antibody detection technology--challenges in interpretation.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Cumulative incidence, indications, morbidity and mortality of transplant nephrectomy and the most appropriate time for graft removal: only nonfunctioning transplants that cause intractable complications should be excised.

Surgical complications of graft nephrectomy in the modern transplant era.

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Long-term survival in renal transplant recipients with graft function.

P304

1310-1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.00260112

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Cardeau-Desangles

Céline Guilbeau-Frugier

Lionel Rostaing

P577

2012-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22626959

http://www.w3.org/2001/XMLSchema#string

P932

3408115

http://www.w3.org/2001/XMLSchema#string